Julie Lotharius

5.0k total citations · 1 hit paper
22 papers, 3.7k citations indexed

About

Julie Lotharius is a scholar working on Cellular and Molecular Neuroscience, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Julie Lotharius has authored 22 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 10 papers in Neurology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Julie Lotharius's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (6 papers) and Malaria Research and Control (6 papers). Julie Lotharius is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (6 papers) and Malaria Research and Control (6 papers). Julie Lotharius collaborates with scholars based in Denmark, United States and Switzerland. Julie Lotharius's co-authors include Patrik Brundin, Karen L. O’Malley, Andreas Hald, Laura L. Dugan, Marcel Leist, Cecilia Lundberg, Heather K. Raymon, Sebastian Barg, Jeppe Falsig and Kevin L. Quick and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Nature reviews. Neuroscience.

In The Last Decade

Julie Lotharius

22 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein

2002 1.0k citations Julie Lotharius, Patrik Brundin Nature reviews. Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie Lotharius Denmark	19	1.6k	1.5k	1.2k	601	472	22	3.7k
Benjamin Drukarch Netherlands	43	1.4k 0.9×	1.6k 1.1×	1.9k 1.5×	809 1.3×	1.1k 2.4×	143	5.4k
Marco Bisaglia Italy	35	1.4k 0.9×	692 0.5×	1.1k 0.9×	733 1.2×	263 0.6×	61	2.9k
Rajnish Kumar Chaturvedi India	33	604 0.4×	1.1k 0.7×	1.8k 1.4×	865 1.4×	425 0.9×	76	4.0k
Yu‐He Yuan China	34	902 0.6×	707 0.5×	1.5k 1.2×	499 0.8×	706 1.5×	97	3.4k
Shankar J. Chinta United States	31	1.2k 0.8×	888 0.6×	1.4k 1.1×	916 1.5×	608 1.3×	56	3.6k
Patricia Muñoz Chile	24	872 0.6×	608 0.4×	755 0.6×	343 0.6×	299 0.6×	50	2.5k
Michael R. Sierks United States	36	665 0.4×	534 0.4×	2.3k 1.9×	1.3k 2.2×	267 0.6×	93	4.3k
Dagmar E. Ehrnhoefer Canada	22	827 0.5×	1.2k 0.8×	2.0k 1.6×	1.8k 3.0×	294 0.6×	34	4.0k
Patrick Emond France	37	637 0.4×	898 0.6×	1.7k 1.4×	375 0.6×	163 0.3×	165	4.0k

Countries citing papers authored by Julie Lotharius

Since Specialization

Citations

This map shows the geographic impact of Julie Lotharius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Lotharius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Lotharius more than expected).

Fields of papers citing papers by Julie Lotharius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Lotharius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Lotharius. The network helps show where Julie Lotharius may publish in the future.

Co-authorship network of co-authors of Julie Lotharius

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Lotharius. A scholar is included among the top collaborators of Julie Lotharius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Lotharius. Julie Lotharius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCarthy, James, Julie Lotharius, Thomas Rückle, et al.. (2017). Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study. The Lancet Infectious Diseases. 17(6). 626–635. 82 indexed citations

Lotharius, Julie, Íñigo Angulo‐Barturen, Julie Clark, et al.. (2014). Repositioning: the fast track to new anti-malarial medicines?. Malaria Journal. 13(1). 143–143. 29 indexed citations

Wittlin, Sergio, Christian Scheurer, Masataka Ihara, et al.. (2013). In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models. Drug Design Development and Therapy. 7. 1377–1377. 10 indexed citations

Burrows, Jeremy N., Didier Leroy, Julie Lotharius, & David Waterson. (2011). Challenges in Antimalarial Drug Discovery. Future Medicinal Chemistry. 3(11). 1401–1412. 50 indexed citations

Johansen, Jens Leander, Thomas Nikolaj Sager, Julie Lotharius, et al.. (2010). HIF prolyl hydroxylase inhibition increases cell viability and potentiates dopamine release in dopaminergic cells. Journal of Neurochemistry. 115(1). 209–219. 42 indexed citations

Lotharius, Julie, et al.. (2010). A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single Enantiomer (+)-Mefloquine Compared with Racemic Mefloquine in Healthy Persons. American Journal of Tropical Medicine and Hygiene. 83(6). 1195–1201. 16 indexed citations

Schildknecht, Stefan, Dominik Pöltl, Florian Matt, et al.. (2009). Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. Toxicology and Applied Pharmacology. 241(1). 23–35. 91 indexed citations

Jensen, Henriette Stokbro, Anna Kirstine Larsen, Mette Lund Pedersen, et al.. (2007). Efficacy of small‐molecule glycogen synthase kinase‐3 inhibitors in the postnatal rat model of tau hyperphosphorylation. British Journal of Pharmacology. 152(6). 959–979. 109 indexed citations

Vergo, Sandra, Jens Leander Johansen, Marcel Leist, & Julie Lotharius. (2007). Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels. Brain Research. 1185. 18–32. 73 indexed citations

10.

Lotharius, Julie, Jeppe Falsig, Johan van Beek, et al.. (2005). Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway. Journal of Neuroscience. 25(27). 6329–6342. 206 indexed citations

11.

Hald, Andreas & Julie Lotharius. (2005). Oxidative stress and inflammation in Parkinson's disease: is there a causal link?. Experimental Neurology. 193(2). 279–290. 411 indexed citations

12.

Falsig, Jeppe, Peter Pörzgen, Julie Lotharius, & Marcel Leist. (2004). Specific Modulation of Astrocyte Inflammation by Inhibition of Mixed Lineage Kinases with CEP-1347. The Journal of Immunology. 173(4). 2762–2770. 62 indexed citations

13.

Lotharius, Julie. (2002). Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. Human Molecular Genetics. 11(20). 2395–2407. 212 indexed citations

14.

Petersén, Åsa, et al.. (2002). Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice. Neurobiology of Disease. 11(1). 134–146. 69 indexed citations

15.

Lotharius, Julie, et al.. (2002). Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line. Journal of Biological Chemistry. 277(41). 38884–38894. 277 indexed citations

16.

Lotharius, Julie & Patrik Brundin. (2002). Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein. Nature reviews. Neuroscience. 3(12). 932–942. 1015 indexed citations breakdown →

17.

Dugan, Laura L., et al.. (2001). Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism & Related Disorders. 7(3). 243–246. 267 indexed citations

18.

Lotharius, Julie & Karen L. O’Malley. (2001). Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity. Annals of Neurology. 49(1). 79–89. 33 indexed citations

19.

Lotharius, Julie & Karen L. O’Malley. (2000). The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation. Journal of Biological Chemistry. 275(49). 38581–38588. 260 indexed citations

20.

Lotharius, Julie, Laura L. Dugan, & Karen L. O’Malley. (1999). Distinct Mechanisms Underlie Neurotoxin-Mediated Cell Death in Cultured Dopaminergic Neurons. Journal of Neuroscience. 19(4). 1284–1293. 349 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact